Anthology leverages innovations in genomic, hardware, and computational biology engineering to accelerate genetic evolution and design custom genomes, expanding the scope of biomanufacturing possibilities. The company aims to use lesser-explored organisms, such as fungi, to produce protein and other products from agricultural, plastic or other waste. Anthology combines modern tools to introduce genetic mutations, analyze phenotypes, and select the most promising genetic variants. Inspired by the work on "jumping genes," Anthology uses mobile genetic elements to create controlled mutations and enhance the abilities of industrial hosts. Anthology's business model relies on partnerships with industry players to prove the effectiveness of its technology and meet market needs by identifying target proteins to be produced.
Source : AFN
